Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone replacement therapy should be used for men with low testosterone levels and symptoms of hypogonadism, after careful diagnosis and considering individual needs.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

The L457(3.43)R mutation in the human lutropin receptor causes increased activity and hormone insensitivity, leading to precocious puberty.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Cimetidine did not reduce hair growth in women with hirsutism.

Certain genetic markers linked to reproductive potential were identified by their impact on a protein's ability to bind to genes.

The study suggests certain ACE gene variations are more common in women with PCOS and may be linked to increased insulin resistance.

CAH is a genetic disorder affecting cortisol production and causing hormonal imbalances, with treatment and diagnosis varying by form and symptoms.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Hormones and genes affect hair growth and male baldness.

Isoallopregnanolone may be a safe and effective treatment for reducing tics in a mouse model of Tourette syndrome.

Finasteride reduces movement issues in Parkinson's disease rats.

Botanicals like green tea extract show potential for hair growth, but more research is needed.

Obesity changes androgen levels in women with PCOS, leading to higher testosterone relative to androstenedione.

Finasteride boosts morphine's pain relief, stops tolerance, and reduces withdrawal in rats.

Hormones affect skin aging and fat distribution, and treatments can help, but only minoxidil is proven for female hair loss.

The document concludes that various cosmetic and drug treatments are available for hirsutism, and some new drugs show promise.

OCT binds strongly to hair sheath cells and may affect skin and hair growth with fewer side effects than vitamin D3.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

Progesterone and its byproducts control a specific receptor in the brain independently of progesterone receptors, affecting conditions related to the menstrual cycle.

Prolactin affects when mice shed and grow hair.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Blocking 5α-reductase can harm memory and brain structure, and increase harmful brain changes in male mice used for Alzheimer's disease research.

Certain drugs change freshwater snail shells to a "banana" shape.

Sex hormones, especially estradiol, can change chicken feather shapes and colors.

Finasteride affects young male rats' brain function and behavior negatively.

Genomic approach finds new possible treatments for hair loss.

5α-reductase inhibitors may worsen sexual drive and spontaneous erections but don't worsen existing erectile or ejaculatory problems.

A woman with acromegaloidism and normal growth hormone levels had a rare X-Tetrasomy, suggesting a need to study X-chromosome genes for their role in growth and facial development.